000 01487nam a2200337 a 4500
001 0000130415
005 20171002061022.0
006 m u
007 cr cn|||||||||
008 110215s2011 dcu sb 000 0 eng d
020 _z9780309163248
020 _z0309163242
035 _a(CaPaEBR)ebr10443278
035 _a(OCoLC)707927323
040 _aCaPaEBR
_cCaPaEBR
050 1 4 _aR853.B54
_bM33 2011eb
100 1 _aMack, Alison.
245 1 0 _aPerspectives on biomarker and surrogate endpoint evaluation
_h[electronic resource] :
_bdiscussion forum summary /
_cAlison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.
260 _aWashington, D.C. :
_bNational Academies Press,
_c2011.
300 _ax, 129 p.
504 _aIncludes bibliographical references (p. 99-102).
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2011.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aBiochemical markers.
655 7 _aElectronic books.
_2local
700 1 _aBalogh, Erin.
700 1 _aMicheel, Christine.
710 2 _aInstitute of Medicine (U.S.).
_bCommittee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.
710 2 _aebrary, Inc.
856 4 0 _uhttp://site.ebrary.com/lib/daystar/Doc?id=10443278
_zAn electronic book accessible through the World Wide Web; click to view
908 _a170314
942 0 0 _cEB
999 _c119564
_d119564